首页|振脾汤对溃疡性结肠炎缓解期患者肠镜下黏膜病变及炎症反应的影响

振脾汤对溃疡性结肠炎缓解期患者肠镜下黏膜病变及炎症反应的影响

扫码查看
目的 研究振脾汤对溃疡性结肠炎(UC)缓解期患者肠镜下黏膜病变及炎症反应的影响。方法 选取 2019 年8 月至 2022 年 7 月江苏大学附属武进医院收治的 90 例UC缓解期患者作为研究对象,采用随机数字表法将其分为观察组与对照组,每组各 45 例。对照组服用美沙拉嗪肠溶片,观察组在对照组基础上服用振脾汤加减方,均连续服用 3 个月。治疗 3 个月后行结肠镜检查,比较 2 组患者临床疗效、治疗前后中医症候积分及黏膜病变严重程度、血清炎症因子水平[白细胞介素 6(IL-6)、白细胞介素 23(IL-23)、肿瘤坏死因子-α(TNF-α)、超敏C反应蛋白(hs-CRP)]、肠道菌群数(双歧杆菌、乳酸杆菌、大肠杆菌、粪肠球菌)、用药期间不良反应(恶心呕吐、头晕头痛、乏力、嗳气)发生率及复发率。结果 观察组治疗总有效率高于对照组(P<0。05)。治疗前 2 组患者腹泻、腹痛、黏液脓血便、里急后重等中医症候积分及Baron评分比较差异均无统计学意义(P>0。05);治疗 3 个月后 2 组患者上述评分均降低,且观察组评分更低(P<0。05)。治疗前 2 组患者hs-CRP、IL-6、TNF-α、IL-23 水平比较差异均无统计学意义(P>0。05);治疗 3 个月后 2 组患者上述指标水平均降低(P<0。05),且观察组更低(P<0。05)。治疗前 2 组患者双歧杆菌、乳酸杆菌、大肠杆菌、粪肠球菌数比较差异均无统计学意义(P>0。05);治疗 3 个月后 2 组患者双歧杆菌、乳酸杆菌数均增加,大肠杆菌、粪肠球菌数均减少(P<0。05);且观察组双歧杆菌、乳酸杆菌数多于对照组,大肠杆菌、粪肠球菌数少于对照组(P<0。05)。观察组不良反应总发生率、复发率均低于对照组(P<0。05)。结论 振脾汤应用于UC缓解期有较好的疗效,可有效缓解患者肠镜下肠黏膜病变,减轻肠胃炎症反应,平衡肠道菌群,具有实际应用价值。
Effects of Zhenpi decoction on mucosal lesions and inflammation in patients with ulcerative colitis at remission stage
Objective To study the effect of Zhenpi decoction on mucosal lesions and inflammatory in patients with ulcerative colitis(UC)at remission stage.Methods A total of 90 remission-stage UC patients admitted to Wujin Hospital Affiliated to Jiangsu University(Wujin Clinical College of Xuzhou University)from August 2019 to July 2022 were enrolled.They were divided into observation group and control group by random number table,with 45 cases in each group.The control group was given mesalazine enteric-coated tablet,and the observation group was given Zhenpi decoction,both for 3 consecutive months.Colonoscopy was performed 3 months after treatment.Clinical effect,traditional Chinese medicine(TCM)syndrome score,the severity of mucosal lesions,serum levels of inflammatory factors(interleukin 6[IL-6],interleukin 23[IL-23],tumor necrosis factor-alpha[TNF-α],hypersensitive C-reactive protein[hs-CRP]),the number of intestinal flora(Bifidobacterium,Lactobacillus,Escherichia coli,Enterococcus faecalis),the incidence and recurrence rates of adverse reactions(nausea and vomiting,dizziness and headache,fatigue and belching)during medication were compared between the 2 groups.Results The total effective rate in the observation group was significantly higher than that in the control group(P<0.05).There were no significant differences in the scores of diarrhea,abdominal pain,mucous pus and blood stool,tenesmus or Baron score between the 2 groups before treatment(P>0.05).After 3-month treatment,the above indexes were significantly decreased in both groups(P<0.05),and the above scores in the observation group were significantly lower than those in the control group(P<0.05).There were no significant differences in hs-CPR,IL-6,TNF-α or IL-23 levels between the 2 groups before treatment(P>0.05).The levels of the above indexes were significantly decreased after 3-month treatment in both groups(P<0.05),and the levels of the above indexes in the observation group were significantly lower than those in the control group(P<0.05).There were no significant differences in the numbers of Bifidobacteria,Lactobacillus,Escherichia coli,or Enterococcus faecalis between the 2 groups before treatment(P>0.05).After 3-month treatment,the numbers of Bifidobacteria and Lactobacillus were significantly increased,while the numbers of Escherichia coli and Enterococcus faecalis were significantly decreased in both groups(P<0.05).After 3-month treatment,the numbers of Bifidobacteria and Lactobacillus were significantly increased,the numbers of Escherichia coli and Enterococcus faecalis were significantly decreased(P<0.05);and the observation group had more Bifidobacteria and Lactobacillus and less Escherichia coli and Enterococcus faecalis than the control group(P<0.05).The total incidence of adverse reactions and recurrence rate in the observation group were significantly lower than those in the control group(P<0.05).Conclusion Zhenpi decoction can effectively relieve intestinal mucosal lesions,reduce gastrointestinal inflammation and balance intestinal flora at UC remission stage.

Zhenpi decoctionUlcerative colitisRemission stageColonoscopyIntestinal mucosaInflammatory response

曾渊杰、蒋婷婷、薛寅

展开 >

213000 江苏 常州,江苏大学附属武进医院(徐州医科大学武进临床学院)中医内科

振脾汤 溃疡性结肠炎 缓解期 结肠镜 肠黏膜 炎症反应

2024

海军医学杂志
海军医学研究所

海军医学杂志

CSTPCD
影响因子:0.518
ISSN:1009-0754
年,卷(期):2024.45(1)
  • 17